QA: Avanir Pharmaceuticals INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000858803_2014_Avanir_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000858803, Avanir Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 71,843,640
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,592,791
3 remainder_Assets 2,642,576
4 LiabilitiesCurrent 34,792,215
5 LiabilitiesNoncurrent 1,393,075
6 remainder_Liabilities 21,422,163
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 29,934,875
9 ResearchAndDevelopmentExpense 49,506,199
10 remainder_Expenses 71,452,556
11 remainder_Revenues 75,365,884
12 remainder_NetIncome 51,883
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 76,079,007
1 Liabilities 57,607,453
2 Expenses 150,893,630
3 Revenues 75,365,884
4 StockholdersEquity 18,471,554
5 NetIncome -75,475,863
6 ComprehensiveNetIncome -75,475,863
7 BaseVar 179,998,928
8 EconomicCapitalRatiobeforeLimitedLiability -0.527
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution

Change over Time